药品注册申请号:078976
申请类型:ANDA (仿制药申请)
申请人:ACTAVIS MID ATLANTIC
申请人全名:ACTAVIS MID ATLANTIC LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML No No AA 2009/01/15 2009/01/15 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2009/01/15 ORIG-1(原始申请) Approval
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2025/03/04 SUPPL-22(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2023/04/06 SUPPL-17(补充) Approval Labeling-Medication Guide,Labeling-Package Insert STANDARD
2023/04/06 SUPPL-16(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2023/04/06 SUPPL-15(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2014/09/26 SUPPL-13(补充) Approval Labeling-Package Insert STANDARD
2014/09/26 SUPPL-11(补充) Approval Labeling-Package Insert STANDARD
2014/09/26 SUPPL-9(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2014/09/26 SUPPL-6(补充) Approval Labeling-Package Insert STANDARD
2010/11/17 SUPPL-4(补充) Approval Labeling-Package Insert
2010/02/16 SUPPL-3(补充) Approval REMS-Proposal
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:LEVETIRACETAM; 剂型/给药途径:SOLUTION;ORAL; 规格:100MG/ML; 治疗等效代码:AA<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
218080 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA -- GUARDIAN DRUG
021505 001 NDA KEPPRA LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription Yes Yes AA 2003/07/15 UCB INC
078582 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/01/15 STRIDES PHARMA
078976 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/01/15 ACTAVIS MID ATLANTIC
079063 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/01/15 AUROBINDO PHARMA
079120 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/01/16 BIONPHARMA
078774 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/02/10 TARO
090263 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/04/03 CHARTWELL MOLECULAR
090992 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2009/10/27 AMNEAL PHARMS
090461 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2010/09/30 AJENAT PHARMS
090893 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2011/10/17 LUPIN LTD
090601 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Discontinued No No AA 2012/02/28 HIKMA
090079 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2012/04/11 QUAGEN
203052 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2013/02/28 HETERO LABS LTD III
203067 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2013/05/09 ALEMBIC
201157 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2015/06/04 PHARM ASSOC
214757 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Prescription No No AA 2022/07/15 MSN
214673 001 ANDA LEVETIRACETAM LEVETIRACETAM SOLUTION;ORAL 100MG/ML Discontinued No No AA 2023/11/20 STRIDES PHARMA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database